Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages
Haithuy Pham, Whitney Medford, Spencer Horst, Melissa Levesque, David Ragoonanan, Christine Price, Harold J. Colbassani, Keaton Piper, Keith Chastain
Topics & Concepts
MedicineRivaroxabanApixabanProthrombin complex concentrateHemostasisIntracerebral hemorrhageAnesthesiaThrombosisEmergency medicineSurgeryInternal medicineGlasgow Coma ScaleWarfarinAtrial fibrillationIntracerebral and Subarachnoid Hemorrhage ResearchAtrial Fibrillation Management and OutcomesSpinal Hematomas and Complications